The ICU LIBERATION Study

Recruiting Observational Study
Acute Respiratory Distress Syndrome Post Intensive Care Syndrome Treatment Compliance Quality of Life
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
16 and older
Sex
Any
Study type
Observational
Participants needed
1,000 (estimated)
Sponsor
Japanese Society for Early Mobilization · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Acute respiratory distress syndrome (ARDS) is a condition associated with hypoxemia due to noncardiogenic causes and results in high mortality. However, the epidemiology and treatment strategy for ARDS may have changed significantly due to the accumulation of a large body of knowledge, following the two-year pandemic of the novel coronavirus (SARS-CoV-2) of which the primary manifestation is ARDS.…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Patients on an invasive or non-invasive ventilator within 24 hours of ICU admission 2. Patients who are expected to be on an invasive and/or non-invasive ventilator for more than 48 hours in total 3. Patients who meet the diagnosis of ARDS within 24 hours of ICU admission Ex…
Contacts

Kensuke Nakamura, MD, PhD

+81-29-231-1111

knakamura-tky@umin.ac.jp

CONTACT